Reports of Practical Oncology and Radiotherapy (RPOR) is committed to prompt evaluation and publication of submitted articles. All manuscripts together with supplementary files should be submitted online at https://mc04.manuscriptcentral.com/rpor. The submission and review process is fully electronic and submissions by e-mail or postal mail will not be accepted. Please follow the manuscript preparation directions presented below. Manuscripts submitted for publication in RPOR are evaluated as to whether they present new insights into the announced topic and are likely to contribute to progress in research or to changes in clinical practice. Received manuscripts are initially examined by the Journal editors. Manuscripts with insufficient priority for publication are rejected immediately to allow the authors to recognize deficiencies and submit the paper to another journal or submit a revised version to RPOR. Incomplete submissions or manuscripts not prepared in the required style (see ′Manuscript Preparation′) are sent back to the authors without scientific review. If manuscript is accepted for review, the authors will be notified in the electronic way only with the reference to the article ID number in the electronic system. Articles are evaluated by at least two outside referees who are contacted before being sent a paper and asked to return comments within 3 weeks. All submitted manuscripts are treated as confidential documents, and reviewers are instructed to treat manuscripts as such. The peer review process is also confidential and identities of reviewers are not released (single blind review mode). Referees are asked to provide a written review together with recommendation of acceptance, requirement for revision or rejection of the article. Submitted papers are accepted for publication after a positive opinion has been returned by the referees. Authors are notified of decisions by e-mail only. Selected papers are edited to improve accuracy and clarity and for length. Papers submitted to RPOR but not accepted for publication may, in some cases, be eligible for publication in other journals of the Publisher.

Reviewers’ criteria for manuscripts qualification

Title reflects the subject undertaken
Assumptions are proper
Work of practical nature
Work of educational nature
Aims are clearly defined
Appropriate methodology*
Ethical criteria fulfilled*
Research-based work*
Results are adequately presented*
Statistical analysis is reliable*
Discussion refers to results*
Conclusions based on study findings*
Conclusions refer to aims*
Suitably chosen, proper number and up to date references
Proper length
All figures and tables are required
Standard of written English acceptable 

*criteria exclusively for research papers

This journal provides immediate open access to its on line content on the principle that making research freely available to the public supports a greater global exchange of knowledge. Articles published in open access are available under Creative Common Attribution-Non Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.

Publisher's policy regarding self-archiving is explained at: Author's Rights panel. It is expected that - irrecpective of manuscrpit version - the acknowledgment will be given to the original source of publication and link will be inserted to final article published at Publisher's website. 

To exclude, even unintentional, plagiarism Reports of Practical Oncology and Radiotherapy has introduced Ithenticate software, widely known in the academic community. All papers accepted for publication will now be automatically screened within the manuscript system. Additionally, Editors may decide to run a similarity report at any other point during the review process or post-publication. Our Editorial team is aware of recognized limitation of this tool and realize that a high similarity score does not necessarily indicate plagiarized text. Thus, every doubtful report will be delt with individually to determine whether there are any grounds for concern.

Reports in Practical Oncology and Radiotherapy (RPOR) will accept advertising for services and products that are of value to readers in their professions. Distinction between advertising and editorial content should be easy. PJNNS does not allow advertising to influence editorial decisions. Online advertising or sponsorship should not impede users’ access to editorial content. Journal accepts advertising from competitors. Advertisements or sponsorship related to tobacco products will not be accepted. Advertisements and sponsorship must be legal, trustworthy and comply with the relevant industry codes, laws and regulations.

This policy applies to complaints on policies, procedures and actions of RPOR editorial staff and as a rule is regarded as an opportunity for improvement. Complaints will be dealt with by members of the editorial staff, escalating (if required) to Editor-in-Chief, whose decision is regarded as final. Complaints should be directly emailed to a person indicated as a support contact at the Journal’s contact panel.  All complaints will be acknowledged within three working days and, if possible, a full response will be made within three weeks. If this is not possible an interim response will be given within this timeframe. Further responses will be provided until the issue is resolved.

If authors are convinced that the article they submitted was rejected wrongly, they should send rebuttal letter via RPOR support contact rather than submitting a revised article at this stage. If the editors agree to such appeal, authors may be asked to submit a revised version of the article in question which will enter again into RPOR review process. The rebuttal letter should be detailed and include responses to comments from external reviewers and from Journal’s editors. Only one appeal per article will be considered. An invitation for resubmission after appealing is by itself not a guarantee of acceptance.

To secure release from the responsibilities to the third parties, corresponding author is required to return to the Publisher a singed copy of the ‘Authors' statement’ together with the manuscript.  All authors must agree to the conditions of publication, however the final responsibility for this information lays on the author submitting the manuscript.

The Authors' statement is available at: link 

Every effort is made by the Editor-in-Chief and the Editorial Board of Reports in Practical Oncology and Radiotherapy (RPOR) to see that no inaccurate or misleading data, opinion or statement appear in RPOR. However, they wish to make it clear that the data and opinions appearing in the articles and advertisements herein are the responsibility of the contributor, sponsor or advertiser concerned. Accordingly, the Editor-in-Chief and the Editorial Board accept no liability whatsoever for the consequences of any such inaccurate of misleading data, opinion or statement. Every effort is made to ensure that drug doses and other quantities are presented accurately. Nevertheless, readers are advised that methods and techniques involving drug usage and other treatments described in RPOR, should only be followed in conjunction with the drug or treatment manufacturer's own published literature in the readers own country.